PrEP-001 prophylactic effect against rhinovirus and influenza virus - RESULTS of 2 randomized trials

BACKGROUND: PrEP-001 Nasal Powder, a proprietary formulation of polyriboinosinic and polyribocytidylic acid effectively elicits a cellular innate immune response in nasal epithelium. The aim of these 2 studies was to investigate the safety and efficacy of PrEP-001 prophylaxis against rhinovirus (HRV...

Descripción completa

Detalles Bibliográficos
Autores principales: Malcolm, Bruce Albert, Aerts, Caroline Anne, Dubois, Kristof Johan, Geurts, Frederik Joris, Marien, Kris, Rusch, Sarah, Van Dijck, Alex Henri, Verloes, Rene, Vingerhoets, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126195/
https://www.ncbi.nlm.nih.gov/pubmed/29567461
http://dx.doi.org/10.1016/j.antiviral.2018.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126195/
https://www.ncbi.nlm.nih.gov/pubmed/29567461
http://dx.doi.org/10.1016/j.antiviral.2018.03.005

Ejemplares similares